Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma

Figure 3

The comparison of biochemical parameters between patients with or without heart failure. (a) ALB (heart failure, ; nonheart failure, ). (b) β2-MG (heart failure, ; nonheart failure, ). (c) Creatine Kinase-MB (CK-MB) (heart failure, ; nonheart failure, ). (d) hs-TNI (heart failure, ; nonheart failure, ). (e) pro-BNP (heart failure, ; nonheart failure, ). (f) End-diastolic volume (EDV)-CF/BAS (heart failure, ; nonheart failure, ). (g) End-systolic volume (ESV)-CF/BAS (heart failure, ; nonheart failure, ). (h) Myocardial mass (CF/BAS) (heart failure, ; nonheart failure, ). (i) Basal ECV (heart failure, ; nonheart failure, ). (j) Apical ECV (heart failure, ; nonheart failure, ). (k) Mid ECV (heart failure, ; nonheart failure, ). (l) Left ventricular ejection fraction (LVEF) (heart failure, ; nonheart failure, ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)